CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 54 enrolled
Drug / intervention
Nicotine polacrilex +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01830842
NCT01830842N/ACompleted

Acute and Chronic Nicotine Modulation of Reinforcement Learning

Duke University·interventional·Posted Apr 12, 2013·Updated Dec 19, 2017

In Brief

A clinical study evaluating Nicotine polacrilex, Placebo, and 2 other interventions for Nicotine Addiction. Completed, enrolled 54 participants across 1 site.

Detailed Summary

The purpose of this study is to use functional magnetic resonance imaging (fMRI) to investigate the acute and chronic effects of nicotine on motivational behavior and prediction error-related neural activation. Nonsmokers (n = 24) and smokers (n = 24) will undergo fMRI scans on two separate occasions while performing a decision-making task that will elicit prediction error signals in the mesocorticolimbic pathway of the brain. Nonsmokers will be scanned once following an acute dose of nicotine and once following placebo administration. Smokers will be scanned once following smoking as usual and once following 24-hours of smoking abstinence, in order to measure the effects of nicotine withdrawal. The study team hypothesizes that acute nicotine will increase the prediction error signal in nonsmokers compared to placebo, and that nicotine withdrawal will decrease the prediction error signal in smokers compared to the normal satiated condition. Furthermore, nonsmokers (during the placebo condition) will have greater prediction error activation than smokers (during the satiated condition). The results of this study will inform whether the initiation and maintenance of smoking behavior could be facilitated by the effects of nicotine on reinforcement learning.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedApr 12, 2013
Enrollment StartFeb 1, 2014
Primary CompletionAug 31, 2016
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 13.2 years ago

Interventions

Nicotine polacrilexdrug

nonsmokers will be measured following nicotine administration

Placebodrug

nonsmokers will be measured following placebo administration

satietyother

smokers will be measured in a smoking satiated condition

abstinenceother

smokers will be measured following 24-hours of smoking abstinence